These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30825554)

  • 1. Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders.
    Toniolo SP; Afkhami S; Mahmood A; Fradin C; Lichty BD; Miller MS; Xing Z; Cranston ED; Thompson MR
    Int J Pharm; 2019 Apr; 561():66-73. PubMed ID: 30825554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying.
    LeClair DA; Cranston ED; Xing Z; Thompson MR
    Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo.
    Toniolo SP; Afkhami S; D'Agostino MR; Lichty BD; Cranston ED; Xing Z; Thompson MR
    Sci Rep; 2020 Aug; 10(1):13349. PubMed ID: 32770018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.
    Price DN; Kunda NK; Ellis R; Muttil P
    Pharm Res; 2019 Dec; 37(1):11. PubMed ID: 31873825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic levitation as a screening method for excipient selection in the development of dry powder vaccines.
    Morgan BA; Xing Z; Cranston ED; Thompson MR
    Int J Pharm; 2019 May; 563():71-78. PubMed ID: 30930189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
    Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
    Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
    Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
    Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Spray Drying Conditions for Yield, Particle Size and Biological Activity of Thermally Stable Viral Vectors.
    LeClair DA; Cranston ED; Xing Z; Thompson MR
    Pharm Res; 2016 Nov; 33(11):2763-76. PubMed ID: 27450412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Robust Freeze-Drying Process for Long-Term Stability of rVSV-SARS-CoV-2 Vaccine.
    Khan MDFH; Youssef M; Nesdoly S; Kamen AA
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
    Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
    Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of HSV-2 viral vaccine candidate by spray drying.
    LeClair DA; Li L; Rahman N; Cranston ED; Xing Z; Thompson MR
    Int J Pharm; 2019 Oct; 569():118615. PubMed ID: 31415872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
    Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
    Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of formulation on spray dried Sabin inactivated polio vaccine.
    Kanojia G; Ten Have R; Brugmans D; Soema PC; Frijlink HW; Amorij JP; Kersten G
    Eur J Pharm Biopharm; 2018 Aug; 129():21-29. PubMed ID: 29787800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprotective agents influence viral dosage and thermal stability of inhalable dry powder vaccines.
    Manser M; Feng X; Xing Z; Cranston ED; Thompson MR
    Int J Pharm; 2022 Apr; 617():121602. PubMed ID: 35189314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying.
    Lovalenti PM; Anderl J; Yee L; Nguyen V; Ghavami B; Ohtake S; Saxena A; Voss T; Truong-Le V
    Pharm Res; 2016 May; 33(5):1144-60. PubMed ID: 26818839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.